Drug Type Small molecule drug |
Synonyms CEE 03320, CEE 320, NNC 220215 |
Target |
Action- |
Mechanism D1 receptor antagonists(Dopamine D1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Preclinical | Denmark | - | |
Sleep Wake Disorders | Preclinical | United Kingdom | - | - |
Substance-Related Disorders | Preclinical | United Kingdom | - | - |
Movement Disorders | Discovery | United Kingdom | 25 May 1999 | |
Unspecified drug dependence | Discovery | United Kingdom | 25 May 1999 |